scPharmaceuticals Inc (SCPH)
NASDAQ:SCPH
US Market
Holding SCPH?
Track your performance easily

scPharmaceuticals (SCPH) Financial Statements

424 Followers

scPharmaceuticals Financial Overview

scPharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.56; its P/E ratio is -2.69; scPharmaceuticals is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 8.05M$ 6.10M$ 6.10M$ 3.80M$ 1.64M
Gross Profit$ 5.75M$ 4.32M$ 4.32M$ 2.72M$ 1.64M
EBIT$ -14.96M$ -12.01M$ -11.72M$ -12.49M$ -11.79M
EBITDA$ -14.78M$ -11.96M$ -11.58M$ -12.92M$ -12.04M
Net Income Common Stockholders$ -17.09M$ -14.11M$ -13.81M$ -15.63M$ -14.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 38.50M$ 58.40M$ 76.01M$ 90.20M$ 102.88M
Total Assets$ 65.46M$ 78.41M$ 94.48M$ 106.10M$ 114.17M
Total Debt$ 41.36M$ 40.80M$ 40.27M$ 39.81M$ 38.01M
Net Debt$ 2.86M$ -17.60M$ -35.74M$ -50.38M$ -64.86M
Total Liabilities$ 56.21M$ 53.89M$ 57.26M$ 56.95M$ 50.74M
Stockholders Equity$ 9.25M$ 24.52M$ 37.22M$ 49.15M$ 63.43M
Cash Flow-
Free Cash Flow$ -20.23M$ -17.70M$ -15.20M$ -13.45M$ -14.14M
Operating Cash Flow$ -20.23M$ -17.70M$ -15.16M$ -13.45M$ -14.14M
Investing Cash Flow$ 1.00K$ 29.32M$ 26.46M$ -22.93M$ 9.43M
Financing Cash Flow$ 283.00K$ 15.00K$ 467.00K$ 68.00K$ 611.00K
Currency in USD

scPharmaceuticals Earnings and Revenue History

scPharmaceuticals Debt to Assets

scPharmaceuticals Cash Flow

scPharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis